Sierra Bancorp And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Sierra Bancorp (BSRR), Diamondback Energy (FANG), Clearwater Paper Corporation (CLW) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Sierra Bancorp (BSRR)

97.4% sales growth and 10.85% return on equity

Sierra Bancorp operates as the bank holding company for Bank of the Sierra that provides retail and commercial banking services to individuals and businesses in California. The company accepts various deposit products, such as checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. Its loan products include agricultural, commercial, consumer, real estate, construction, and mortgage loans. The company also offers automated teller machines; electronic point-of-sale payment alternatives; online and automated telephone banking services; and remote deposit capture and automated payroll services for business customers. As of December 31, 2021, it operated 35 full-service branches, an online branch, a loan production office, an agricultural credit center, and an SBA center. Sierra Bancorp was founded in 1977 and is headquartered in Porterville, California.

Earnings Per Share

As for profitability, Sierra Bancorp has a trailing twelve months EPS of $2.45.

PE Ratio

Sierra Bancorp has a trailing twelve months price to earnings ratio of 11.23. Meaning, the purchaser of the share is investing $11.23 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.85%.

Sales Growth

Sierra Bancorp’s sales growth is 8.9% for the ongoing quarter and 97.4% for the next.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jul 31, 2024, the estimated forward annual dividend rate is 0.96 and the estimated forward annual dividend yield is 3.49%.

Volume

Today’s last reported volume for Sierra Bancorp is 15959 which is 60.38% below its average volume of 40290.

Moving Average

Sierra Bancorp’s value is under its 50-day moving average of $28.70 and way above its 200-day moving average of $22.79.

2. Diamondback Energy (FANG)

44.7% sales growth and 21.34% return on equity

Diamondback Energy, Inc., an independent oil and natural gas company, acquires, develops, explores, and exploits unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas. It focuses on the development of the Spraberry and Wolfcamp formations of the Midland basin; and the Wolfcamp and Bone Spring formations of the Delaware basin, which are part of the Permian Basin in West Texas and New Mexico. The company also owns and operates midstream infrastructure assets, in the Midland and Delaware Basins of the Permian Basin. Diamondback Energy, Inc. was founded in 2007 and is headquartered in Midland, Texas.

Earnings Per Share

As for profitability, Diamondback Energy has a trailing twelve months EPS of $17.35.

PE Ratio

Diamondback Energy has a trailing twelve months price to earnings ratio of 11.89. Meaning, the purchaser of the share is investing $11.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.34%.

Volume

Today’s last reported volume for Diamondback Energy is 1464890 which is 19.73% below its average volume of 1825000.

3. Clearwater Paper Corporation (CLW)

24.8% sales growth and 7.16% return on equity

Clearwater Paper Corporation produces and sells private label tissue and bleached paperboard products in the United States and internationally. The company operates through two segments, Consumer Products, and Pulp and Paperboard. The Consumer Products segment manufactures and sells a line of at-home tissue products, including bath tissues, paper towels, facial tissues, and napkins; recycled fiber value grade products; and away-from-home products and parent rolls. This segment sells its products to retailers and wholesale distributors, including grocery, drug, mass merchants, and discount stores. The Pulp and Paperboard segment manufactures and markets bleached paperboard, folding cartons, liquid packaging, cups and plates, blister and carded packaging, top sheet and commercial printing grades and softwood pulp products, as well as offers custom sheeting, slitting and cutting of paperboard. It sells its products to packaging converters, folding carton converters, merchants, and commercial printers. Clearwater Paper Corporation was incorporated in 2005 and is headquartered in Spokane, Washington.

Earnings Per Share

As for profitability, Clearwater Paper Corporation has a trailing twelve months EPS of $2.63.

PE Ratio

Clearwater Paper Corporation has a trailing twelve months price to earnings ratio of 10.58. Meaning, the purchaser of the share is investing $10.58 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.16%.

Sales Growth

Clearwater Paper Corporation’s sales growth is 20% for the ongoing quarter and 24.8% for the next.

Yearly Top and Bottom Value

Clearwater Paper Corporation’s stock is valued at $27.83 at 20:22 EST, way below its 52-week high of $57.13 and above its 52-week low of $25.50.

Volume

Today’s last reported volume for Clearwater Paper Corporation is 258101 which is 13.06% below its average volume of 296906.

Moving Average

Clearwater Paper Corporation’s value is under its 50-day moving average of $30.28 and way below its 200-day moving average of $40.17.

4. First Hawaiian (FHB)

24.6% sales growth and 9.04% return on equity

First Hawaiian, Inc. operates as a bank holding company for First Hawaiian Bank that provides a range of banking services to consumer and commercial customers in the United States. It operates in three segments: Retail Banking, Commercial Banking, and Treasury and Other. The company accepts various deposit products, including checking and savings accounts, and time deposit accounts. It also provides residential and commercial mortgage loans, home equity lines of credit, automobile loans and leases, personal lines of credit, installment loans, and small business loans and leases, commercial lease financing, and auto dealer financing. In addition, the company offers personal installment, credit card, individual investment and financial planning, insurance protection, trust and estate, private banking, retirement planning, treasury, and merchant processing services. As of December 31, 2020, it operated 54 branches in Oahu, Maui, Hawaii, Kauai, Lanai, Guam, and Saipan. The company was formerly known as BancWest Corporation and changed its name to First Hawaiian, Inc. in April 2016. The company was founded in 1858 and is headquartered in Honolulu, Hawaii. First Hawaiian, Inc. is a subsidiary of BancWest Corporation.

Earnings Per Share

As for profitability, First Hawaiian has a trailing twelve months EPS of $1.74.

PE Ratio

First Hawaiian has a trailing twelve months price to earnings ratio of 13.53. Meaning, the purchaser of the share is investing $13.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.04%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 4.3% and positive 10.8% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 802.87M for the twelve trailing months.

Volume

Today’s last reported volume for First Hawaiian is 415746 which is 32.67% below its average volume of 617487.

5. Catalyst Pharmaceuticals (CPRX)

16.7% sales growth and 13.85% return on equity

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Earnings Per Share

As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.63.

PE Ratio

Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 24.16. Meaning, the purchaser of the share is investing $24.16 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.85%.

Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $15.22 at 20:22 EST, way under its 52-week high of $21.85 and way above its 52-week low of $11.89.

Sales Growth

Catalyst Pharmaceuticals’s sales growth is 23% for the current quarter and 16.7% for the next.

Volume

Today’s last reported volume for Catalyst Pharmaceuticals is 817840 which is 36.47% below its average volume of 1287390.

6. CrossFirst Bankshares (CFB)

8.5% sales growth and 10.35% return on equity

CrossFirst Bankshares, Inc. operates as the bank holding company for CrossFirst Bank that provides various banking and financial services to businesses, business owners, professionals, and its personal networks. The company offers commercial real estate, construction and land development, 1-4 family real estate, multifamily real estate, commercial and industrial, energy, and consumer loans. It also provides a range of deposit products consisting of non-interest-bearing demand and interest-bearing deposits, which include transaction accounts, savings accounts, money market accounts, and certificates of deposit; and personal and business checking and savings accounts, as well as negotiable order of withdrawal accounts; and brokered and reciprocal deposits. In addition, the company offers international banking services; treasury management services; automated teller machine access; and mobile banking services. Further, it holds investments in marketable securities. It has full-service banking offices in Kansas, Missouri, Oklahoma, Arizona, Colorado, New Mexico, and Texas. CrossFirst Bankshares, Inc. was founded in 2007 and is headquartered in Leawood, Kansas.

Earnings Per Share

As for profitability, CrossFirst Bankshares has a trailing twelve months EPS of $1.42.

PE Ratio

CrossFirst Bankshares has a trailing twelve months price to earnings ratio of 11.39. Meaning, the purchaser of the share is investing $11.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.35%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 236.86M for the twelve trailing months.

Leave a Reply

Your email address will not be published. Required fields are marked *